Iterum Therapeutics plc
8-K
March 27, 2026
Key Highlights
- FDA approval of ORLYNVAHâ„¢ achieved on October 25, 2024
- Company has filed a petition for liquidation in the Irish High Court
- Appointment of Joint Provisional Liquidators to manage asset sales
Read Analysis
🤖 AI Generated